Black Diamond Therapeutics (BDTX) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order virtually to facilitate broader stockholder participation and was conducted in accordance with company bylaws and Delaware law.

• The agenda included formal business as described in the proxy statement, with questions limited to official business before voting and a general Q&A after polls closed.

Board and executive committee updates

• Current board members and executive officers were introduced, including the presence of independent auditors and legal counsel.

Corporate governance

• Voting eligibility and procedures were outlined, with Broadridge Financial Solutions as tabulator and Richard L. Leza appointed as Inspector of Election.

• A quorum was confirmed with nearly 78% of shares represented.